E-FPMI-8 - Transcription profiling of human CD14+ monocytes treated with innate defence regulator peptide IDR-1 in the presence/absence of lipopolyssacharide

Status
Submitted on 25 July 2006, released on 10 April 2007, last updated on 1 May 2014
Organism
Homo sapiens
Samples (15)
Array (1)
Protocols (10)
Description
Effect of peptide IDR-1 on CD14+ human monocytes. >br< >br< Effect of peptide IDR-1 on LPS-induced responses in CD14+ human monocytes.>br< >br< Human peripheral blood mononuclear cells (PBMC) were treated with innate defence regulator peptide IDR-1 in the presence and absence of LPS (purified from Pseudomonas aeruginosa) for 4hrs. The objective was to obtain a transcriptional profile of responses induced by IDR-1 and the effect of IDR-1 on LPS-induced transcription.
Experiment types
transcription profiling by array, compound treatment
Contact
Citation
An anti-infective peptide that selectively modulates the innate immune response. Scott MG, Dullaghan E, Mookherjee N, Glavas N, Waldbrook M, Thompson A, Wang A, Lee K, Doria S, Hamill P, Yu JJ, Li Y, Donini O, Guarna MM, Finlay BB, North JR, Hancock RE. Nat Biotechnol 25:465-472 (2007)
MIAME
PlatformsProtocolsFactorsProcessedRaw
Files
Investigation descriptionE-FPMI-8.idf.txt
Sample and data relationshipE-FPMI-8.sdrf.txt
Raw data (1)E-FPMI-8.raw.1.zip
Experiment designE-FPMI-8.biosamples.png, E-FPMI-8.biosamples.svg
Array designA-FPMI-4.adf.txt
Links